Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Shannon

Showing results (201-210 of 245) with videos related to

Pageof 25
Sort By:
Annals of Surgical Oncology|April 28, 2025
Cartilage Resection in the Surgical Management of Ear MelanomaElan Novis, Joyce Tan, Danielle Vignati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia NomogramSerigne N Lo, Jiawen Ma, Richard A Scolyer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2024
Clinical significance of intra-thoracic and intra-abdominal sentinel lymph nodes detected on lymphoscintigraphy in truncal melanoma patientsElan Novis, Ahmad Sulaiman, Jonathan Stretch, et al.
Annals of Surgical Oncology|May 27, 2024
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 MelanomasAlec A Winder, Zoe Boyer, Sydney Ch'ng, et al.
Journal of the American Academy of Dermatology|September 7, 2024
Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: Implications for systemic therapyAndrew T Li, Jessie X Xu, Tyler R Blah, et al.
Melanoma Research|May 17, 2022
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spreadAndrew T Li, Jia Miin Yip, Harsham Choksi, et al.
Nature Medicine|June 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF<sup>V600</sup>-mutant resectable melanoma: the randomized phase 2 NeoTrio trialGeorgina V Long, Matteo S Carlino, George Au-Yeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Pageof 25

Showing results (201-210 of 245) with videos related to

Sort By:
Pageof 25
Annals of Surgical Oncology|April 28, 2025
Cartilage Resection in the Surgical Management of Ear MelanomaElan Novis, Joyce Tan, Danielle Vignati, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 13, 2020
Improved Risk Prediction Calculator for Sentinel Node Positivity in Patients With Melanoma: The Melanoma Institute Australia NomogramSerigne N Lo, Jiawen Ma, Richard A Scolyer, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2024
Clinical significance of intra-thoracic and intra-abdominal sentinel lymph nodes detected on lymphoscintigraphy in truncal melanoma patientsElan Novis, Ahmad Sulaiman, Jonathan Stretch, et al.
Annals of Surgical Oncology|May 27, 2024
Impact of an Online Risk Calculator for Sentinel Node Positivity on Management of Patients with T1 and T2 MelanomasAlec A Winder, Zoe Boyer, Sydney Ch'ng, et al.
Journal of the American Academy of Dermatology|September 7, 2024
Comparison of clinicopathological features and treatment outcomes for cutaneous melanomas of the head and neck and melanomas arising at other sites: Implications for systemic therapyAndrew T Li, Jessie X Xu, Tyler R Blah, et al.
Melanoma Research|May 17, 2022
Lack of association between anatomical sites of scalp melanomas and brain metastases does not support direct vascular spreadAndrew T Li, Jia Miin Yip, Harsham Choksi, et al.
Nature Medicine|June 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAF<sup>V600</sup>-mutant resectable melanoma: the randomized phase 2 NeoTrio trialGeorgina V Long, Matteo S Carlino, George Au-Yeung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 16, 2024
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanomaA M Menzies, S N Lo, R P M Saw, et al.
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Pageof 25